Orthopedic healthcare solution developer b-ONE has secured over 100 million yuan ($14 million) in a new round funding led by Wuxi Municipal government-backed Taihu Fund, and AI-driven industrial fintech company KnowLeGene has raised 100 million yuan ($14 million) in a Series B round of financing led by JC Capital.
b-ONE raises over $14m in a new round
b-ONE Ortho Corp, an orthopedic healthcare solution developer, has garnered over 100 million yuan ($14 million) in a new round funding led by Wuxi Municipal government-backed Taihu Fund. F-Prime Capital and existing investor Eight Roads joined the round, according to a company statement.
Founded in 2015, b-ONE specializes in developing innovative orthopedic healthcare solutions to restore motion and improve surgical outcomes.
The USFDA approved its propriety product, MOBIO, in October 2018 while, in August last year, its JUVENO solution got approval.
Headquartered in New Jersey and Shanghai, b-ONE has also set up offices in Bristol, Beijing and Suzhou.
b-ONE will invest in market expansion and work on its product pipeline. In 2018, b-ONE had closed an undisclosed round of financing from Eight Roads.
KnowLeGene snags $14m in Series B round
AI-driven industrial financial technology company KnowLeGene has raised 100 million yuan ($14 million) in a Series B round of financing led by Beijing-based JC Capital, per a company statement.
The government of Hebei province backed China Zhongji Investment and existing investors Lingfeng Capital have also participated in the current round. InvesTarget, a cross-border investment bank, acted as financial advisor for the deal.
KnowLeGene has tied up with the University of Chinese Academy of Sciences to build an AI laboratory. It develops smart solutions to cater to sectors including supply chain, risk control, sales & marketing, among others.
Proceeds will be used to accelerate product enhancements, customer relations management and business development.